Drug delivery systems for the treatment of restenosis

Michael Chorny, Ilia Fishbein, Gershon Golomb*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations

Abstract

Attempts to achieve revascularization of coronary arteries blocked by atherosclerotic plaques are hampered by restenotic hyperproliferative response of the treated vessels. The uniform failure of clinical trials using systemic therapies to prevent restenosis has prompted development of methods for arterial drug delivery systems. This review describes technologies of polymeric-based, perivascular, and intraluminal drug and gene delivery systems. The critical assessment of controversies including drug and vehicle type, dose and release rate, and preclinical validation is reviewed.

Original languageEnglish
Pages (from-to)249-284
Number of pages36
JournalCritical Reviews in Therapeutic Drug Carrier Systems
Volume17
Issue number3
DOIs
StatePublished - 2000

Keywords

  • Controlled release
  • Drug delivery systems
  • Nanoparticles
  • Polymeric-based drug delivery
  • Restenosis

Fingerprint

Dive into the research topics of 'Drug delivery systems for the treatment of restenosis'. Together they form a unique fingerprint.

Cite this